跳至主要内容
临床试验/NCT00236249
NCT00236249已完成3 期

Evaluation of Lidocaine Continuous Intravenous Administration for Postoperative Recovery After Colorectal Surgery

Assistance Publique - Hôpitaux de Paris2 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2005年5月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
110
试验地点
2
主要终点
Readiness for discharge, checked twice a day

研究概览

简要总结

The purpose of this study is to check if lidocaine intravenous administration during surgery and 24 hours after surgery, associated with standardised management of the patient, helps to accelerate recovery and to improve the quality of recovery, after surgery for colic or rectal neoplasms.

详细描述

One of the purposes of postoperative care is to shorten the duration of recovery, in order to reduce the complications and to improve the quality of life. After abdominal surgery, two factors can be modified: early mobilisation, thanks to optimal pain control, and return to a normal feeding, permitted by transit recovery. Opioids, which are usually used for pain control, delay the intestinal transit and can be responsible for side effects like drowsiness, nausea, urine retention.

Lidocaine is a local anaesthetic, which means that it can stop the pain if it is administrated around the nerves. It can also be used intravenously. In this way, it is supposed to decrease opioid consumption, accelerate intestinal transit and even decrease inflammation. Side effects of lidocaine appear at higher plasma concentrations than those considered in the study.

After randomisation, the patient will receive either intravenous lidocaine during the surgery and 24 hours after the surgery, or physiological serum (like placebo). Every patient will dispose of patient-controlled-analgesia with morphine and of a standardised care management. Data will be collected concerning pain level, morphine consumption, psychomotor performances, duration of ileus, speed of activity recovery, quality of recovery, and side effects. Biological evaluation of lidocaine concentration and inflammation will also be done.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Colorectal neoplasm
  • Radical surgery
  • Median incision

排除标准

  • American Society of Anesthesiologists (ASA) score equal to or up to 3
  • Unwilling or unable to use patient-controlled analgesia (PCA)
  • Chronic consumption of opioids
  • Chronic drug or alcohol abuse
  • Chronic pain
  • Unable to read or write text
  • Inflammatory disease of intestinal tract
  • Allergy to morphine
  • Allergy to lidocaine
  • Severe atrioventricular conduction dysfunction without stimulator
  • Uncontrolled epilepsy
  • History of malign hyperthermia
  • Severe cardiac failure
  • Hepatic failure
  • Myasthenia
  • Treatment with beta blockers, antiarrhythmic calcium blockers, sultopride, nonselective monoamine oxidase inhibitor (MAOI)
  • Locoregional anaesthesia planned
  • Associated surgery concerning liver, pancreas, or gall bladder
  • Laparoscopic surgery
  • Severe psychiatric pathology
  • Refusal of the patient

结局指标

主要结局

Readiness for discharge, checked twice a day

次要结局

  • Clinical side effects twice a day
  • Pain every 4 hours the first day after surgery, then twice a day
  • Morphine consumption: dose of titration, then twice a day
  • Time of transit recovery
  • Physical rehabilitation score daily
  • Psychomotor test daily until reaching of preoperative values
  • Quality of recovery score at 1st, 3rd, and 6th day
  • Satisfaction score at discharge
  • Biological inflammation the day before the surgery, then at 1st, 3rd, and 6th day
  • Lidocaine concentration at the end of surgery and 24 hours forward

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验